Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Aulos Bioscience, Inc.
Aulos Bioscience, Inc.
Hoffmann-La Roche
PMV Pharmaceuticals, Inc
Mayo Clinic
Tasca Therapeutics
Kidney Cancer Research Bureau
Second Life Therapeutics
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
VM Oncology, LLC
Takeda
GI Innovation, Inc.
Sensei Biotherapeutics, Inc.
Incyte Corporation
Yuhan Corporation
NuCana plc
Medicenna Therapeutics, Inc.
invoX Pharma Limited
Hutchmed
Kymab Limited
PureTech
Vaccinex Inc.
CJ Bioscience, Inc.
Nykode Therapeutics ASA
NextCure, Inc.
Salubris Biotherapeutics Inc
Purple Biotech Ltd.
NantCell, Inc.
Turning Point Therapeutics, Inc.
NextCure, Inc.
NKGen Biotech, Inc.
SQZ Biotechnologies
OncoResponse, Inc.
Nektar Therapeutics
Institut Bergonié
MedImmune LLC
Incyte Corporation
Eli Lilly and Company
NKGen Biotech, Inc.
MultiVir, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Kyowa Kirin Co., Ltd.
Bristol-Myers Squibb